EQRx Overview

  • Founded
  • 2019
Founded
  • Status
  • Public
  • Employees
  • 259
Employees
  • Stock Symbol
  • EQRX
Stock Symbol
  • Investments
  • 3
  • Share Price
  • $3.06
  • (As of Monday Closing)

EQRx General Information

Description

EQRx Inc is a biotechnology company. Its pipeline programs include two pre-registrational oncology assets that have shown assuring Phase 3 data (aumolertinib and sugemalimab), and multiple other clinical-stage programs.

Contact Information

Website
www.eqrx.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Stock Exchange
NAS
Primary Office
  • 50 Hampshire Street
  • Cambridge, MA 02139
  • United States
+1 (617) 000-0000

EQRx Timeline

202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

EQRx Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.06 $3.09 $2.63 - $8.70 $1.51B 488M 1.07M -$0.57

EQRx Financials Summary

In Thousands,
USD 		TTM 30-Sep-2021 FY 2020 31-Dec-2020
Revenue 0 0
EBITDA (277,946) (249,742)
Net Income (278,846) (249,983)
Total Assets 484,659 500,528
Total Debt 4,088 5,085
Public Fundamental Data provided by Morningstar, Inc. disclaimer

EQRx Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore EQRx‘s full profile, request access.

Request a free trial

EQRx Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion
Price		 % Owned

This information is available in the PitchBook Platform. To explore EQRx‘s full profile, request access.

Request a free trial

EQRx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
EQRx Inc is a biotechnology company. Its pipeline programs include two pre-registrational oncology assets that have show
Drug Discovery
Cambridge, MA
259 As of 2021
00.000
000000000 00.000

00000000

isi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit es
0000 000000000
San Francisco, CA
000 As of 0000
00000
0000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

EQRx Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
00000000 Venture Capital-Backed San Francisco, CA 000 00000 0000000000 00000
You’re viewing 1 of 1 competitors. Get the full list »

EQRx Executive Team (15)

Name Title Board Seat Contact Info
Melanie Nallicheri Chief Executive Officer & Founder
Jami Rubin Chief Financial Officer
Jami Rubin Chief Financial Officer, Finance
Max Duffy Director of Corporate Strategy
Christian Antoni Executive
You’re viewing 5 of 15 executive team members. Get the full list »

EQRx Board Members (14)

Name Representing Role Since
Alexis Borisy Self Chairman & Founder 000 0000
Amy Abernethy Ph.D EQRx Board Member 000 0000
Clive Meanwell MD Self Board Member 000 0000
Clive Meanwell Ph.D Self Board Member 000 0000
Eli Casdin CM Life Sciences III Board Member 000 0000
You’re viewing 5 of 14 board members. Get the full list »

EQRx Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

EQRx Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore EQRx‘s full profile, request access.

Request a free trial

EQRx Investments & Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00 0000 00000 17-Dec-2021 0000000000 Special Purpose Acquisition Company (SPAC) 000000 00
000000 000000 16-Nov-2021 00000 0000 000.00 Drug Discovery
Crimson BioPharm 04-Oct-2019 Early Stage VC 000 Biotechnology
To view EQRx’s complete investments and acquisitions history, request access »